Annualized relapse rate of first-line treatments for multiple sclerosis: A meta-analysis, including indirect comparisons versus fingolimod

Not yet translated Not yet translated
Authors
Category Systematic review
JournalNeurology
Year 2012
This article has no abstract
Epistemonikos ID: 3ec874581c815c04f96fe6b14f86acebe5fe9b4d
First added on: Nov 23, 2016